April 9, 2013
/PRNewswire/ - Bontan Corporation Inc. ('the Company") (OTCBB: BNTNF) ("Bontan") is pleased to announce that it has incorporated a newly formed company, Portage Acquisition Inc. ("PAI"), incorporated under the laws of the
British Virgin Islands
PAI is currently a wholly owned subsidiary of the Company and will facilitate early closing of the proposed acquisition of Portage Pharma Ltd. through a BVI statutory merger, as previously announced in a press release dated
March 26, 2013
Bontan Corporation Inc. has recently signed a letter of intent to acquire Portage Pharma Ltd through a share exchange. Portage Pharma Ltd. currently holds a master licence to the Antennapedia platform for all pathologies (except oncology). Upon closing of the Portage Pharma Ltd. acquisition the Company will be engaged in researching and developing products through to proof of concept with an early focus on unmet clinical needs and orphan drugs. Following proof of concept, the Company will look to sell or licence the products to Big Pharma.
About Bontan Corporation Inc:
Bontan Corporation Inc. concluded a settlement on its indirect oil and gas interest in
and now seeks business opportunities in the biotechnology sector.
For further information, contact
, Chief Executive Officer of Bontan, at (416) 929-1806 and for investor relations contact
at (416) 860-0211.
This news release includes forward-looking statements within the meaning of the U.S. federal and Canadian securities laws. Any such statements reflect Bontan's current views and assumptions about future events and financial performance. Bontan cannot assure that future events or performance will occur. Important risks and factors that could cause actual results or events to differ materially from those indicated in our forward-looking statements.